2025 Fall
MCELLBI 120L 001 - LEC 001
Therapeutics Discovery Laboratory
Ross C Wilson, Roberto Zoncu
Class #:34140
Units: 4
Instruction Mode:
In-Person Instruction
Offered through
Molecular and Cell Biology
Current Enrollment
Total Open Seats:
0
Enrolled: 24
Waitlisted: 0
Capacity: 24
Waitlist Max: 0
No Reserved Seats
Hours & Workload
1 hours of instructor presentation of course materials per week, 3 hours of outside work hours per week, and 8 hours of instructional experiences requiring special laboratory equipment and facilities per week.
Final Exam
FRI, DECEMBER 19TH
08:00 am - 11:00 am
Stanley 177
Other classes by Ross C Wilson
Other classes by Roberto Zoncu
Course Catalog Description
This lab course will familiarize students with general principles of drug discovery and action. The first module focuses on aspects of small molecule function by comparing stoichiometric inhibitors and PROTAC molecules against the BTK kinase. Students will learn how to purify protein, monitor drug binding and in vitro efficiency, and determine effects on cell survival. The second module focuses on genomic therapies by introducing students to principles of CRISPR genome editing. Students will design genome editing strategies and cognate guide RNAs and then perform an editing experiment that replaces a catalytic Cys residue in BTK with Ser. Students will compare stoichiometric inhibitors against BTK to PROTAC in wildtype or mutant cells.
Rules & Requirements
Repeat Rules
Course is not repeatable for credit.
Reserved Seats
Reserved Seating For This Term
Textbooks & Materials
See class syllabus or https://calstudentstore.berkeley.edu/textbooks for the most current information.
Guide to Open, Free, & Affordable Course Materials